New antibody drug aims to calm painful skin condition
NCT ID NCT06993610
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This Phase 2 trial tests tibulizumab, a dual-action antibody, in 225 adults with hidradenitis suppurativa (HS), a chronic skin condition causing painful abscesses. Participants first receive either the drug or a placebo for 16 weeks, then everyone gets the drug for another 16 weeks. The goal is to see if tibulizumab reduces the number of abscesses and inflammatory nodules.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
tibulizumab (an antibody that targets BAFF and IL-17 to reduce inflammation)
What this could lead to
If successful, this could provide a new treatment option for hidradenitis suppurativa, potentially reducing painful flare-ups and improving quality of life.
What could go wrong
This is an early Phase 2 trial with only 225 participants, so results may not apply to everyone. The drug may cause side effects or fail to show significant benefit over placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA (HS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Apex Clinical Research Center
Mayfield Heights, Ohio, 44124, United States
-
BRCR Global Texas
Katy, Texas, 77450, United States
-
Best Skin Research LLC
Camp Hill, Pennsylvania, 17011, United States
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Centre de recherche Saint-Louis
Québec, Quebec, G1W 4R4, Canada
-
Centrum Badawcze Panaceum Agnieszka Brzezicka, Magdalena Lenkiewicz Sp z .o.o
Malbork, 82200, Poland
-
ClinOhio Research Services
Columbus, Ohio, 43213, United States
-
Clinical Trials Management, LLC
Metairie, Louisiana, 70006, United States
-
DS Research of Kentucky, LLC
Louisville, Kentucky, 40241, United States
-
DelRicht LLC
Baton Rouge, Louisiana, 70809, United States
-
DelRicht Research
Mt. Pleasant, South Carolina, 29464, United States
-
DelRicht Research
Prosper, Texas, 75078, United States
-
Dermatology Specialists of Spokane
Spokane, Washington, 99202, United States
-
Dermatology Treatment and Research Center
Dallas, Texas, 75230, United States
-
Edificio IMIBIC, Reina Sofia University Hospital
Córdoba, 14004, Spain
-
Equity Medical
New York, New York, 10023, United States
-
Equity Medical LLC (Kentucky)
Bowling Green, Kentucky, 42104, United States
-
Fachklinik Bad Bentheim
Bad Bentheim, 48455, Germany
-
First OC Dermatology Research, Inc.
Irvine, California, 92614, United States
-
Florida Academic Dermatology Center
Coral Gables, Florida, 33134, United States
-
Frontier Dermatology
Mill Creek, Washington, 98012, United States
-
Georgia Skin & Cancer Clinic
Savannah, Georgia, 31419, United States
-
Gregorio Marañón General University Hospital
Madrid, 28007, Spain
-
Hospital Universitario La Paz
Madrid, 28046, Spain
-
Hospital Universitario Miguel Servet
Zaragoza, 50009, Spain
-
Indiana University School of Medicine
Indianapolis, Indiana, 46202, United States
-
International Clinical Research - Tennessee LLC
Murfreesboro, Tennessee, 37130, United States
-
Katholische Klinikum Bochum gGmbH
Bochum, 44791, Germany
-
Klinik und Poliklinik für Dermatologie und Allergologie
München, 80337, Germany
-
Klinikum Darmstadt
Darmstadt, 64283, Germany
-
Laser Clinic S.C.
Szczecin, 70-332, Poland
-
Manufaktura Zdrowia i Urody
Warsaw, 02-922, Poland
-
MediSearch Clinical Trials
Saint Joseph, Missouri, 64506, United States
-
Medical Dermatology Specialists (Phoenix)
Phoenix, Arizona, 85006, United States
-
NorCal Clinical Research
Rocklin, California, 95765, United States
-
North York Research Inc
North York, Ontario, M2J 5B2, Canada
-
Northridge Clinical Trials
Northridge, California, 91325, United States
-
OptiSkin Medical
New York, New York, 10128, United States
-
Optima Research
Boardman, Ohio, 44512, United States
-
Palmetto Clinical Trial Services
Anderson, South Carolina, 29625, United States
-
Progressive Clinical Research
San Antonio, Texas, 78213, United States
-
Provita Centrum Medyczne Sp. z o.o. Katowice
Katowice, 40-611, Poland
-
Provita Sp. z o. o.
Katowice, 40-611, Poland
-
RENEW Clinic
Bialystok, 15-797, Poland
-
Red River Research Partners
Fargo, North Dakota, 58103, United States
-
Ryan Clinical Research Inc.
Newmarket, Ontario, L3Y 5G8, Canada
-
SOLUMED
Poznan, 60-425, Poland
-
Saskatoon Dermatology Centre
Saskatoon, Saskatchewan, S7T 0G3, Canada
-
Semmelweis University
Budapest, 1085, Hungary
-
Skin Cancer and Dermatology Institute
Reno, Nevada, 89509, United States
-
Skin Care Research, LLC
Hollywood, Florida, 33021, United States
-
The Indiana Clinical Trials Center
Plainfield, Indiana, 46168, United States
-
University Clinic Dermatology Heidelberg
Heidelberg, 69120, Germany
-
University Hospital Dresden
Dresden, 01307, Germany
-
University Hospital Muenster - Münster
Münster, 48149, Germany
-
University of Debrecen
Debrecen, 4032, Hungary
-
University of Szeged
Szeged, 6720, Hungary
-
University of Washington Medical Center
Seattle, Washington, 98164, United States
-
Versorgungsforschung in der Dermatologie und bei Pflegeberufen (IVDP)
Hamburg, 20251, Germany
-
Wallace Medical Group, Inc.
Los Angeles, California, 90056, United States
-
York Dermatology Clinic & Research Centre
Richmond Hill, Ontario, L4B 1L1, Canada